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Abstract
Background:  Previously we showed that reduced availability of the essential amino acid
tryptophan per se attenuates post-transcriptional control of interleukin (IL)-6 and IL-8 leading to
hyperresponsive production of these inflammatory mediators by airway epithelial cells. Availability
of the non-essential amino acid arginine in the inflamed airway mucosa of patients with asthma is
reduced markedly, but it is not known whether this can also lead to an exaggerated production of
IL-6 and IL-8.
Methods: IL-6 and IL-8 were determined by ELISA in culture supernatants of NCI-H292 airway
epithelial-like cells and normal bronchial epithelial (NHBE) cells that were exposed to TNF-α, LPS
or no stimulus, in medium with or without arginine. Arginine deficiency may also result from
exposure to poly-L-arginine or major basic protein (MBP), which can block arginine uptake.
Epithelial cells were exposed to these polycationic proteins and L-14C-arginine uptake was assessed
as well as IL-6 and IL-8 production. To determine the mode of action, IL-6 and IL-8 mRNA profiles
over time were assessed as were gene transcription and post-transcriptional mRNA degradation.
Results:  For both NCI-H292 and NHBE cells, low arginine concentrations enhanced basal
epithelial IL-6 and IL-8 production and synergized with TNF-α-induced IL-6 and IL-8 production.
Poly-L-arginine enhanced the stimulus-induced IL-6 and IL-8 production, however, blocking
arginine uptake and the enhanced IL-6 and IL-8 production appeared unrelated. The exaggerated
IL-6 and IL-8 production due to arginine deficiency and to poly-L-arginine depend on a post-
transcriptional and a transcriptional process, respectively.
Conclusion: We conclude that both reduced arginine availability per se and the presence of
polycationic proteins may promote airway inflammation by enhanced pro-inflammatory mediator
production in airway epithelial cells, but due to distinct mechanisms.
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Background
Asthma is an inflammatory airway disease characterized
by intermittent and variable degrees of airway obstruction
and bronchial hyperresponsiveness [1-3]. There are sev-
eral studies that point to enhanced arginine catabolism in
airways of patients with asthma, which may lead to
reduced local bioavailability of arginine. Arginine is
catabolised to the potent smooth muscle cell relaxing
component nitric oxide (NO) and L-citrulline by constitu-
tive nitric oxide synthases (neuronal NOS and endothelial
NOS) and the inducible nitric oxide synthase (iNOS).
Enhanced NO levels are found in exhaled air of patients
with asthma, which reflects particularly the enhanced
expression of iNOS in airway epithelial cells [4,5]. Fur-
thermore, a study by Kochansky and colleagues [6]
showed enhanced arginase activity in sputum from
patients with asthma. This was independently corrobo-
rated in a study by Zimmerman et al. [7] showing abun-
dant expression of arginase-I at the mRNA and protein
level in airway epithelial cells from patients with asthma.
Increased enzymatic activity was confirmed by showing
reduced arginine levels in serum samples from exacerbat-
ing asthmatics [8], suggestive of a larger depletion of
arginine locally in the airways.
Our previous studies into the regulation of the production
of inflammatory mediators, exemplified by key pro-
inflammatory interleukin(IL)-6 and IL-8, by airway epi-
thelial cells have shown that reduced levels of the essential
amino acid tryptophan, which affects cellular metabo-
lism, led to exaggerated production of these mediators by
post-transcriptional mechanisms [9]. It is unknown
whether reduced levels of arginine per se give rise to sim-
ilar exaggerated mediator responses. Arginine is a non-
essential amino acid, acquired by eukaryotic cells by syn-
thesis in the Krebs urea cycle and uptake via the cationic
amino acid transporters (CAT; [10-14]). CATs are blocked
by polycations like major basic protein (MBP). MBP is
present in airways of asthmatics and thus may also lead to
reduced arginine availability to cells, even in the presence
of extracellular arginine [15]. We were interested to assess
whether reduced extracellular arginine levels as well as
blocking arginine uptake by polycations would influence
the epithelial production of the inflammatory mediators
IL-6 and IL-8.
Methods
Cell culture and experimental set up
NCI-H292 cells (CRL 1848; American Type Culture Col-
lection [ATCC], Manassas, VA) were cultured and propa-
gated in RPMI 1640 medium with 10% fetal calf serum
(FCS), 100 U/ml penicillin, 100 μg/ml streptomycin and
1.2 mM L-glutamine (H292 medium). For some experi-
ments, cells were incubated with minimum essential
medium Eagle (MEM), modified with Earle's salts, 2 g/L
sodium bicarbonate without L-glutamine and L-arginine
(ICN Biomedicals, Zoetermeer, the Netherlands) supple-
mented with L-glutamine, penicillin and streptomycin as
indicated above. For mediator release, 3 × 105 cells were
plated and cultured overnight in 500 μl in 24-well plates.
For isolation of mRNA and nuclear extracts, 15 × 105 cells
were plated and cultured overnight in 2.5 ml in 6-well
plates. Cells were washed and then exposed in fresh
medium for 20 hours to doses of pathophysiologically rel-
evant stimuli, i.e. recombinant human TNF-α (R&D sys-
tems, Minneapolis, MN), LPS (Sigma Chemical Co., St.
Louis, MO) or recombinant human IFN-γ (Roche Molec-
ular Biochemicals) up to 5 ng/ml, 5 μg/ml or 100 U/ml,
respectively. When indicated arginine, poly-L-arginine,
heparin (Merck; Nottingham, UK) or N-Nitro-arginine
Methyl Ester (L-NAME; Sigma Chemical Co.) were added.
For a number of experiments we used primary bronchial
epithelial cells (NHBE; Lonza Benelux BV). NHBE cells
were cultured and propagated as recommended by the
supplier, and cells were used between passage 3 and 5. For
cytokine production, 0.2 × 105 cells were plated in 48-well
plates, and before exposure to stimuli, cells were washed
with PBS and incubated with MEM plus or minus
arginine. Cell cultures were screened on a routine basis for
Mycoplasma by PCR and were found negative. In all
experiments t = 0 is collected directly after all cells were
exposed to the indicated experimental conditions.
L-14C-arginine uptake
NCI-H292 cells (6 × 104 cells) were plated in 100 μl H292
medium per well in a 96-well plate. After overnight incu-
bation, cells were washed with 100 μl Hank's balanced
salt solution (HBSS) without arginine and then exposed
to poly-L-arginine or major basic protein (MBP) in 100 μl
HBSS. Then, 10 μl per well of 100 μM L-14C-arginine
(Amersham Biosciences, UK) was added. After 30 min-
utes, cells were washed 3 times with 100 μl HBSS and
lysed for 5 minutes in a final 0.1% (v/v) Triton X-100 in
PBS. After the addition of 100 μl scintillation fluid, radio-
activity was counted.
Measurement of IL-6 or IL-8 protein and mRNA
IL-6 and IL-8 in culture supernatants were measured by
sandwich ELISA, as described before [16,17]. Total RNA
was extracted with Trizol (Invitrogen, Paisley, UK) and IL-
6, IL-8 and GAPDH mRNA were determined by dotblot-
ting and hybridization with specific 32P-labeled probes for
IL-6, IL-8 and GAPDH as described [18,19]. Previous stud-
ies had confirmed that dotblotting yielded similar results
as Northern blotting [9,20,21]. Blots were quantified
using a phosphorimager and variable loading was cor-
rected by expressing mRNA levels relative to that of the
housekeeping gene GAPDH. mRNA decay was deter-
mined 2 hours after stimulation by co-incubation with 5
μg/ml of the transcriptional blocker actinomycin-DRespiratory Research 2009, 10:62 http://respiratory-research.com/content/10/1/62
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(Sigma Chemical Co.). At time zero and after an addi-
tional 40 and 80 minutes, remaining IL-6 and IL-8 mRNA
were determined, as described above.
Transcriptional activity
Transcriptional activity was assessed by measuring a
reporter protein under strict control of the IL-6 or IL-8
promoter. To that end, NCI-H292 cells were grown to
70% confluence in 6-well plates and transfected with 5 μg
of chloramphenicol acetyltransferase (CAT) reporter con-
struct driven by the wild-type IL-8 [22] or IL-6 promoter
[23], as described [18-20]. Cells were stimulated as indi-
cated, 24 h after transfection and 18 h before cell lysis.
CAT production was measured by CAT ELISA (Roche
Diagnostics, Mannheim, Germany) according to the man-
ufacturer's protocol and all data were normalized for total
protein content.
Statistics
All parameters and comparisons were performed using
SPSS 11.5 software. Data are expressed as means ± stand-
ard error of the mean (SEM). The paired or Independent-
Samples t-test and Pearson Correlation were used when
appropriate to evaluate statistical significance. For multi-
ple comparisons we used one-way ANOVA, followed by
least significance difference when equal variances are
assumed or Dunnett's T3 when no equal variances are
assumed, and the multi-regression model method. Differ-
ences were considered significant at P ≤ 0.05.
Results
Reduced levels of arginine enhanced IL-6 and IL-8 
production by airway epithelial cells
The normal cell culture medium for NCI-H292 cells,
RPMI-1640 medium (containing 1 mM arginine) supple-
mented with L-glutamine, penicillin, streptomycin and
10% FCS (with < 100 μM arginine), thus contains
between 0.9 to 1 mM arginine. Initial studies showed that
NCI-H292 cells can be maintained in RPMI-1640
medium without FCS for a week without evident morpho-
logical and functional (IL-6 and IL-8 production) effects
on the cells, and further, that RPMI-1640 medium can be
replaced with MEM, which allowed us to control extracel-
lular arginine levels. Figures 1A and 1B show that the
basal as well as LPS- and TNF-α-stimulated IL-6 and IL-8
production was similar for NCI-H292 cells maintained in
either RPMI-1640 medium or MEM supplemented with L-
glutamine and arginine (MEM-A+). LPS, however, acted as
a poor stimulus in the absence of FCS. The IL-6 and IL-8
production by cells maintained in MEM without arginine
(MEM-A-), as compared to that of cells in medium con-
taining 1 mM arginine (MEM-A+) or in RPMI-1640
medium was markedly increased (IL-6: P < 0.001, P =
0.001 and P < 0.001; IL-8: P = 0.048, P = 0.005 and P =
0.037 for non-stimulated, LPS- and TNF-α-stimulated
cells, respectively). At 20 μM and 5 μM arginine, IL-6 and
IL-8 (not shown) production were still significantly
enhanced over that at 1 mM arginine (Figure 1C). In fact,
between 0 to 1 mM arginine, the concentration of
arginine inversely correlated with IL-6 production (r = -
0.513; p = 0.03). We did not find a similar correlation for
IL-8 production between 0 to 1 mM arginine.
Primary bronchial epithelial cells (NHBE) could be kept
in MEM medium for a limited period only as cell mor-
phology changed and cells detached over time. NHBE
cells in MEM-A- for 21 h displayed enhanced production
of IL-8 as compared to NHBE cells in MEM-A+, in the
absence of a stimulus (P = 0.001), with LPS (P = 0.003),
but not with TNF-α (P = 0.11; Figure 1D). Similar findings
were obtained for IL-6 (Figure 1E). LPS, however, proved
a poor stimulus of IL-6 and IL-8 production by NHBE cells
at these culture conditions, i.e. in the absence of FCS.
Hyperresponsive IL-6 and IL-8 production by reduced 
levels of arginine
In a previous study [9], in which the content of the essen-
tial amino acid tryptophan in culture medium was
reduced, NCI-H292 cells displayed hyperresponsive IL-6
and IL-8 production to stimuli. When NCI-H292 cells
were exposed to MEM medium with or without arginine
we observed a hyperresponsive IL-6 and IL-8 production
to TNF-α for cells in MEM-A- (Figures 2A and 2B; dose
dependency in MEM-A- r = 0.945, P < 0.001; r = 0.967, P
< 0.001, respectively). For cells in MEM-A-, no hyperre-
sponsive IL-6 and IL-8 production to LPS was found, but
merely an enhanced production in MEM-A-, similar to
that found in the absence of a stimulus (Figures 2C and
2D; dose dependency in MEM-A- r = 0.346, P = 0.271; r =
0.668, P = 0.018, respectively).
Polycations enhance IL-6 and IL-8 production to LPS, 
independent of inhibition of arginine uptake
Polycations like poly-L-arginine can inhibit cationic
amino acid transporter proteins, among which those
transporting arginine. We reasoned that the synergy in IL-
6 and IL-8 production shown in the absence of extracellu-
lar arginine may also be accomplished by inhibiting
arginine uptake with poly-L-arginine. Experiments to
measure the effect of poly-L-arginine on L-14C-arginine
uptake and on IL-6 and IL-8 production were performed
in parallel, where L-14C-arginine uptake was assessed
shortly after adding poly-L-arginine and IL-6 and IL-8
were measured in culture supernatants collected at 20 h
after adding poly-L-arginine. Figure 3A shows that 10 and
20  μg/ml poly-L-arginine markedly reduced L-14C-
arginine uptake (P < 0.001), and even at 1.25 to 5 μg/ml
poly-L-arginine, arginine-uptake was inhibited signifi-
cantly (P < 0.05 and P < 0.01, respectively). Forty μg/ml
poly-L-arginine and higher appeared cytotoxic with cellsRespiratory Research 2009, 10:62 http://respiratory-research.com/content/10/1/62
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Enhanced production of IL-6 and IL-8 by airway epithelial cells as a function of arginine Figure 1
Enhanced production of IL-6 and IL-8 by airway epithelial cells as a function of arginine. NCI-H292 cells were 
plated and, after overnight culture, exposed for 24 h to fresh medium (RPMI-1640 plus L-glutamine, MEM plus L-glutamine and 
arginine (MEM-A+) and MEM with L-glutamine only (MEM-A-)) without and with stimuli (LPS: 5 μg/ml; TNF-α: 5 ng/ml). Typical 
experiment (A; IL-6 production; B: IL-8 production) is shown out of three experiments (triplicate samples; mean ± SEM, *P < 
0.05; **P ≤ 0.001). Error bars may be contained within the bar. C) IL-6 production as a function of arginine concentration rela-
tive to IL-6 production in the absence of arginine (*P ≤ 0.019). D) IL-8 production by NHBE cells in MEM-A+ and MEM-A- 
medium (*P ≤ 0.003). E) IL-6 production by NHBE cells after 8 h. in MEM-A+ and MEM-A- medium (*P ≤ 0.012).
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detaching and thus was not tested further. Interestingly,
basal IL-6 and IL-8 production were not affected by poly-
L-arginine itself in contrast to the enhanced basal IL-6 and
IL-8 production due to reduced arginine availability. At
1.25  μg/ml and higher, poly-L-arginine significantly
potentiated LPS-induced IL-8 (P < 0.001) and IL-6 pro-
duction (data not shown) with maximal synergy at 5 μg/
ml of poly-L-arginine. Thus, inhibition of arginine uptake
and the enhanced production of IL-8 and IL-6 did not cor-
relate strictly. Heparin (10 μg/ml) fully inhibited the
effect of poly-L-arginine on the LPS-induced IL-8 and IL-6
production, indicative of a role for the positive charges of
poly-L-arginine. In contrast to the findings for LPS and to
that seen after stimulation with TNF-α of NCI-H292 cells
in MEM-A-, TNF-α did not synergize with poly-L-arginine
in IL-6 and IL-8 production (data not shown). Exposure of
NCI-H292 cells to LPS and poly-L-arginine resulted in a
hyperresponsive IL-6 and IL-8 production (P = 0.015 and
0.046, respectively) (Figures 4A and 4B).
The eosinophilic polycation major basic protein (MBP) is
present in airways secretions from patients with asthma.
We next determined whether MBP, like poly-L-arginine,
inhibited L-14C-arginine uptake and potentiated IL-6 and
IL-8 production. MBP at 10 μg/ml largely increased the
LPS-induced IL-8 (Figure 3B; P < 0.001) and IL-6 (data not
shown) production, apparently independent of blocking
uptake of L-14C-arginine (r = 0.06, P = 0.878) by NCI-
H292 cells.
In contrast to NCI-H292 cells, poly-L-arginine did not
block arginine-uptake by NHBE cells (data not shown).
Distinct from findings with the NCI-H292 cells, poly-L-
arginine enhanced IL-6 and IL-8 production by NHBE
cells in the absence of a stimulus (t = 13.161, P < 0.0001;
t = 11.49, P < 0.0001; t = 10.045, P < 0.0001; t = 8.894, P
< 0.0001, respectively for Figure 5A, B, C, D). TNF-α, but
not LPS significantly synergized with poly-L-arginine in
IL-6 and IL-8 production by NHBE cells, (multi regression
Hyper-responsive IL-6 (A, C) and IL-8 (B, D) production by NCI-H292 cells maintained in MEM without arginine Figure 2
Hyper-responsive IL-6 (A, C) and IL-8 (B, D) production by NCI-H292 cells maintained in MEM without 
arginine. Cells were plated and, after overnight culture, exposed for 20 h to fresh medium (MEM plus L-glutamine and 
arginine (MEM-A+) or MEM with L-glutamine only (MEM-A-)) to a concentration range of TNF-α (A, B) and LPS (C, D). Typi-
cal experiment is shown out of three experiments (triplicate samples; mean ± SEM). *P < 0.05, **P < 0.01 and ***P < 0.001 as 
compared to MEM-A+.Respiratory Research 2009, 10:62 http://respiratory-research.com/content/10/1/62
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model; t = 7.264, P < 0.0001 (5C); t = 6.002, P < 0.0001
(5D); t = -1.693, P = 0.098 (5A); t = -0.738, P = 0.464 (5B).
Regression coefficients of curves with 10 μg/ml poly-L-
arginine are steeper than those of 5 and 0 μg/ml poly-L-
arginine).
Enhanced IL-6 and IL-8 production by poly-L-arginine and 
reduced arginine levels: two distinct mechanisms
At suboptimal concentrations of arginine, iNOS has been
shown to give rise to both NO and superoxide, yielding
the potent oxidant peroxynitrite [11,24,25], that pro-
motes tissue damage and thus inflammation [26]. Even
though iNOS mRNA is expressed not or to a low extent in
resting cells only, we assessed the contribution of NOS to
IL-6 and IL-8 production by both NCI-H292 and NHBE
cells using the non-specific NOS inhibitor L-NAME at var-
ious concentrations (0.01, 0.1 and 1 mM) and multiple
conditions (no stimulus, LPS, TNF-α, poly-L-arginine and
interferon gamma (IFN-γ)). Overall we found that L-
NAME did not reduce IL-6 and IL-8 production unless
cells were exposed to IFN-γ, which induced iNOS mRNA.
NCI-H292 cells exposed to IFN-γ (100 U/ml) for 24 h
were found to produce IL-6 and IL-8, which was inhibited
for 50% by L-NAME.
To further explore the different mechanisms underlying
the exaggerated IL-6 and IL-8 production by reduced
arginine levels versus that by poly-L-arginine, we deter-
The effect of polycations poly-L-arginine and major basic protein on L-14C-arginine uptake and LPS-induced IL-8 production by  NCI-H292 cells Figure 3
The effect of polycations poly-L-arginine and major basic protein on L-14C-arginine uptake and LPS-induced IL-
8 production by NCI-H292 cells. Parallel cultures of NCI-H292 cells were exposed to different amounts of poly-L-arginine 
(A,B) or major basic protein (MBP; C,D). For arginine uptake (A, C) cells were washed with HBBS and L-14C-arginine was 
added for 30 min. (see Material and Methods). For IL-8 (B, D) and IL-6 (not shown) production the culture supernatants were 
collected after 20 h with no stimulus (white columns) or with 5 μg/ml LPS (black columns). Typical experiments are shown 
(triplicate samples; mean ± SEM) of 5 experiments with poly-L-arginine and 4 with MBP. *P < 0.05, **P < 0.01 and ***P < 0.001 
for IL-8 production as compared to unstimulated cells; # P < 0.05, # # P < 0.01 and # # # P < 0.001 for uptake of L-14C-
arginine as compared to that in the absence of poly-L-arginine or MBP.
0 1.25 2.50 5.00 10.0 20.0
0
2000
4000
6000 A
###
###
## ##
#
 L-14C-Arginine
p-L-arginine (Pg/ml)
C
P
M
0 5.00 10.0
0
3000
6000
9000
12000
C
##
MBP (Pg/ml)
C
P
M
0 5.00 10.0
0
500
1000
1500
2000
2500 D
###
#
##
***
***
**
MBP (Pg/ml)
I
L
-
8
 
(
p
g
/
m
l
)
0 1.25 2.50 5.00 10.0 20.0
0
5000
10000
15000
20000
***
***
***
**
B
 no LPS
 LPS
***
###
###
###
###
###
***
p-L-arginine (Pg/ml)
I
L
-
8
 
(
p
g
/
m
l
)Respiratory Research 2009, 10:62 http://respiratory-research.com/content/10/1/62
Page 7 of 12
(page number not for citation purposes)
mined the IL-6 and IL-8 mRNA profiles in NCI-H292 cells
over time for both conditions (Figure 6). In line with our
previous findings, LPS increased IL-8 and IL-6 mRNA 2- to
3-fold at 2 h, followed by a decrease at 4 h. Exposure to
LPS and poly-L-arginine led to a significant 7- to 8-fold
increase of IL-6 and IL-8 mRNA at 2 h, suggestive of an
enhanced transcriptional activity. Subsequently, IL-6 and
IL-8 mRNA levels decreased and reached a plateau at 6 h,
2 to 3 times higher than LPS alone (Figures 6A and 6B).
TNF-α induced IL-6 and IL-8 mRNA 2- to 3-fold at 1 h in
NCI-H292 cells in MEM-A+. In the absence of arginine,
basal IL-6 and IL-8 mRNA levels are enhanced, in line
with the enhanced basal production of IL-6 and IL-8.
These enhanced mRNA levels, however, at large run paral-
lel to those for cells in the presence of arginine, suggestive
of no enhanced transcriptional activity. The peak for IL-6
mRNA (Figure 6C) appeared slightly broader, suggestive
of an attenuated IL-6 mRNA degradation. At 24 h, the IL-
6 mRNA levels increased, but this varied from one to
another experiment (Figure 6C).
The mRNA profiles with poly-L-arginine are indicative of
an enhanced transcriptional activity, and thus we trans-
fected NCI-H292 cells with 5 μg of chloramphenicol
acetyltransferase (CAT) reporter constructs driven by the
wild-type IL-6 or IL-8 promoter. Poly-L-arginine induced
IL-6 and IL-8 gene transcription as deduced by quantifica-
tion of CAT (Figure 7). In the absence of arginine, there
was no further enhanced transcriptional activity as deter-
mined with CAT reporter constructs (data not shown).
Previously we have shown that the hyperresponsive IL-6
and IL-8 production in the absence of tryptophan was due
to a reduced IL-6 and IL-8 mRNA degradation [9]. IL-6
and IL-8 mRNA degradation at low arginine levels and 2
hrs after stimulation, using actinomycin D to block tran-
scription, however, did not reveal a reduced mRNA degra-
dation.
Discussion
The catabolism of arginine in airways of patients with
asthma is enhanced and may lead to reduced bioavailabil-
ity of arginine. Here we show that the reduced arginine
levels per se may contribute to inflammation by mediat-
ing an exaggerated epithelial production of pro-inflam-
matory mediators. We anticipated that polycationic
proteins, that are abundantly present in the airways of
patients with asthma and that have been shown to atten-
uate cellular arginine uptake, would also lead to exagger-
ated IL-6 and IL-8 production. The synthetic polycation
poly-L-arginine and major basic protein (MBP) triggered
an exaggerated IL-6 and IL-8 production, but this
appeared not related to reduced arginine uptake.
The exaggerated IL-6 and IL-8 production by NCI-H292
airway epithelial cells due to arginine deficiency was
ablated at arginine concentrations above 20 μM. The
arginine concentration in airways of patients with asthma
is not known, and when known, this concentration may
deviate from that of the micro-milieu surrounding the air-
way epithelial cells. Enzymes expressed by airway epithe-
lial cells of patients with asthma and that catabolise
arginine are arginase I and II (EC 3.5.3.1) and the induci-
ble nitric-oxide synthases (iNOS; EC 1.14.13.39). The Km
values for arginase I, II and nitric-oxide synthase at physi-
ological pH are 0.08 mM, 4.8 mM and 0.0044 mM,
respectively [27]. iNOS gives rise to both superoxide and
NO at suboptimal levels of arginine, yielding the potent
oxidant peroxynitrite [11,24,25] that promotes tissue
damage and thus inflammation [26]. As peroxynitrite-
derived nitrotyrosines are found in exhaled breath con-
densates of patients with asthma [28] this suggests that
arginine concentrations in airways of asthmatics are
below 4.4 μM. In a study by Heinzel and coworkers [25]
the brain nitric-oxide synthase was found to produce
hydrogen peroxide (as a measure of superoxide) maxi-
mally at 1 μM arginine and lower. Taken together this
indicates that the concentration range of arginine that
Hyper-responsive IL-6 (A) and IL-8 (B) production by NCI- H292 cells exposed to poly-L-arginine Figure 4
Hyper-responsive IL-6 (A) and IL-8 (B) production by 
NCI-H292 cells exposed to poly-L-arginine. Cells were 
exposed for 20 h to normal medium with or without 5 μg/ml 
poly-L-arginine and a concentration range of LPS. Typical 
experiment out of 5 is shown (triplicate samples; mean ± 
SEM). **P < 0.01 and ***P < 0.001 as compared to in the 
absence of poly-L-arginine.
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gives rise to exaggerated IL-6 and IL-8 responses by airway
epithelial cells may occur at pathophysiological condi-
tions. In our experimental set up NOS activity did not
contribute to the exaggerated IL-6 and IL-8 responses. In
vivo, however, iNOS activity may be present and give rise
to peroxynitrites that further aggravate inflammation.
Although we did not primarily aim to clarify the underly-
ing mechanism for the exaggerated IL-6 and IL-8 produc-
tion, the mRNA profile and the lack of a further increased
transcriptional activity suggest that the low arginine con-
centrations affect the post-transcriptional regulation of IL-
6 and IL-8 production. Similar findings were obtained ear-
lier for airway epithelial cells exposed to reduced levels of
the essential amino acid tryptophan [9]. At reduced tryp-
tophan levels, IL-6 and IL-8 mRNA degradation was atten-
uated, resulting in markedly enhanced IL-6 and IL-8
mRNA levels (i.e. superinduction). Despite the reduced
protein synthesis capacity of cells, these enhanced levels
of IL-6 and IL-8 mRNA apparently outcompete other
mRNAs for the remaining translational activity, giving rise
to exaggerated IL-6 and IL-8 production. Our findings
with reduced arginine concentrations did not convinc-
ingly show a reduced IL-6 and IL-8 mRNA degradation.
This may be due to the fact that arginine is also produced
by the cells themselves and thus the effect on protein syn-
thesis and therefore on IL-6 and IL-8 mRNA degradation
may be less than for tryptophan. This is corroborated by
the relatively small increase in IL-6 and IL-8 mRNA levels
compared to that for control cells and in comparison to
that in the absence of tryptophan [9]. Alternatively, we
can not as yet exclude the possibility that the IL-6 and IL-
8 mRNA degradation is affected at time points beyond
that we have assessed now.
Effect of poly-L-arginine on basal, LPS- and TNF-α-induced IL-6 (B, D) and IL-8 (A, C) production by NHBE cells Figure 5
Effect of poly-L-arginine on basal, LPS- and TNF-α-induced IL-6 (B, D) and IL-8 (A, C) production by NHBE 
cells. Cells were exposed for 20 h to normal medium with or without 5 μg/ml poly-L-arginine and a concentration range of 
LPS or TNF-α. One out of two experiments is shown (triplicate samples; mean ± SEM). Poly-L-arginine significantly enhanced 
TNF-α-induced IL-6 and IL-8 production (P < 0.0001 and P < 0.0001, respectively).
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Polycationic proteins, such as those derived from degran-
ulating eosinophils, cause bronchial hyperresponsiveness
and airway inflammation in experimental animal models
upon introduction of the airways [10,29,30]. Although
these polycationic proteins are cytotoxic, at lower doses
they inhibit the uptake of arginine via the cationic amino
acid transporters (CAT; [15]). This reduced uptake of
arginine was shown to limit NO production which was
found to underlie the bronchial hyperresponsiveness [29-
31]. The polycationic peptide poly-L-arginine inhibits
arginine uptake more effectively than other cationic pro-
teins [32], as indeed was confirmed here for MBP and epi-
thelial cells. Poly-L-arginine and MBP potently induced
IL-6 and IL-8 production by epithelial cells, but this did
not coincide with maximal inhibition of arginine uptake,
suggesting that it is independent of blocking arginine
uptake. In addition, poly-L-arginine promoted transcrip-
tional activity which was not seen for reduced arginine
levels. So, we propose that the exaggerated IL-6 and IL-8
production by polycationic proteins is not due to reduced
arginine availability. Interestingly, this synergism on
inflammatory mediator production has been described
before for LPS-stimulated human whole blood with poly-
L-arginine [33]. As poly-L-arginine binds to CD14 [12]
and since a close interaction between CD14 and TLR4 is
required for adequate LPS stimulation [34] it may be
argued that poly-L-arginine promotes the physical interac-
tion of CD14 and TLR4 giving rise to NFκB activation
[35,36]. As NHBE cells are relatively unresponsive to LPS
[37] it is not surprising that we found no synergism
between poly-L-arginine and LPS in the IL-6 and IL-8 pro-
duction by NHBE.
For experimental reasons (see Material and Methods), the
arginine uptake experiments were performed at 10 μM
arginine and the experiments for IL-6 and IL-8 production
at about 1 mM arginine. Since Hammermann et al. (Fig-
ure 5 in [15]) showed that inhibition of arginine uptake
IL-6 and IL-8 mRNA expression in NCI-H292 cells stimulated by LPS in the absence or presence of 5 μg/ml poly-L-arginine (A,  B) or that of arginine (C, D) Figure 6
IL-6 and IL-8 mRNA expression in NCI-H292 cells stimulated by LPS in the absence or presence of 5 μg/ml 
poly-L-arginine (A, B) or that of arginine (C, D). IL-6 and IL-8 mRNA levels were corrected for GAPDH mRNA. Typical 
experiments are shown (triplicate samples; mean ± SEM) of 4 (for poly-L-arginine) and 2 (for arginine) experiments for IL-6 as 
well as IL-8 mRNA. *P < 0.05, **P < 0.01 and ***P < 0.001 as compared to parallel samples in the absence of poly-L-arginine or 
presence of arginine.
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by poly-L-arginine is similar at 0 and 100 μM arginine in
the medium, it is likely that poly-L-arginine also inhibited
arginine uptake markedly at 1 mM arginine. As yet we can
not exclude that reduced arginine uptake also contributed
to the poly-L-arginine-induced exaggerated IL-6 and IL-8
responses. Interestingly we showed that TNF-α in the pres-
ence of poly-L-arginine synergized in IL-6 and IL-8 pro-
duction by NHBE cells. Previously, Visigalli et al. [38]
found that human endothelial cells exposed to TNF-α
stimulate arginine uptake via NF-κB. So, if TNF-α pro-
motes arginine uptake by NHBE cells, poly-L-arginine
may counteract and cause a relative arginine deficiency,
leading to enhanced IL-6 and IL-8 production. Alterna-
tively, we can not exclude that the prolonged incubation
with poly-L-arginine, as is manifest during the 20 h incu-
bation for cytokine production, culminates in a more pro-
found inhibition of arginine uptake and consequently
enhances IL-6 and IL-8 production as shown for reduced
arginine concentrations.
Comparison of the current findings for both NCI-H292
and NHBE cells reveals some important similarities as
well as differences. Both cell types display exaggerated IL-
6 and IL-8 responses in arginine-deficient media in the
absence of stimuli and in the presence of TNF-α, indicat-
ing that this is a general feature of airway epithelial cells,
at least in vitro. LPS failed to induce exaggerated IL-6 and
IL-8 responses in arginine-deficient media, but this is due
to the absence of FCS (see Figure 1). In FCS, soluble CD14
and LPS-binding protein are present which promote bind-
ing of LPS to cells and enhance production of mediators
[39]. This does not exclude an alternative explanation, i.e.
that NHBE cells, at least in vitro, are less responsive to LPS.
The findings for poly-L-arginine appear quite different
between NCI-H292 and NHBE cells. Whereas poly-L-
arginine and MBP partially inhibit arginine uptake by
NCI-H292 cells, we found no effect of poly-L-arginine on
arginine uptake by NHBE cells. NCI-H292 cells are tumor-
derived cells which typically display an enhanced meta-
bolic activity, and thus these cells may have a higher need
for extracellular arginine, as opposed to NHBE cells, mak-
ing the NCI-H292 cells more vulnerable to inhibitors of
arginine uptake. Despite this difference, both NCI-H292
and NHBE cells exposed to poly-L-arginine display exag-
gerated IL-6 and IL-8 responses in the presence of poly-L-
arginine, albeit in response to different stimuli. Our find-
ings for LPS-stimulated NCI-H292 cells in the presence of
poly-L-arginine indicate that poly-L-arginine synergizes
with LPS (Figure 4) leading to an enhanced transcrip-
tional activity (Figures 6 and 7). Poly-L-arginine may bind
to the overall negatively charged cellular membranes and
in this way trigger gene transcription. The different
responses of NHBE and NCI-H292 cells to LPS in the pres-
ence of poly-L-arginine may relate to the low responsive-
ness of NHBE cells to LPS in vitro.
In the current study we have focussed on IL-6 and IL-8,
both key immune-regulatory mediators. IL-6 and IL-8 are
encoded by labile mRNAs, which is a common feature of
mRNAs encoding mediators such VEGF and IP-10. There-
fore the current results for IL-6 and IL-8 responses may
Modulation of IL-6 (A) and IL-8 (B) promoter-driven transcription by LPS and poly-L-arginine Figure 7
Modulation of IL-6 (A) and IL-8 (B) promoter-driven transcription by LPS and poly-L-arginine. Cells were trans-
fected with an IL-6 or IL-8 promoter-driven chloramphenicol acetyltransferase (CAT)-expressing vector. Transfected cells 
were exposed to normal medium (Med), medium containing 5 μg/ml lipopolysaccharide (LPS), medium containing 5 μg/ml poly-
L-arginine (PLA) or medium containing LPS plus PLA (LPS+PLA) for 18 h, respectively. The production of CAT was measured 
by ELISA. Mean ± SD of three experiments are shown. **P < 0.01 and ***P < 0.001 as compared to Med, #P < 0.05 and ###P < 
0.001 as compared to LPS+PLA.
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apply as well to responses of other mediators that are pro-
duced by epithelial cells.
Whether these exaggerated IL-6 and IL-8 responses due to
reduced arginine bioavailability and/or reduced uptake of
arginine are manifest in vivo remains to be tested. Two
recent experimental animal studies addressed the role of
arginase in allergic inflammation by inhibiting arginase
activity; one showing attenuation of inflammation [40],
whereas the other [41] showed an increase. Arginine bio-
availability depends not only on arginase activity and
involves amongst others iNOS activity and the presence of
polycationic proteins, which may contribute to the oppo-
site findings with the two animal studies. In the current
study we have tested the effect of poly-L-arginine on IL-6
and IL-8 production in the presence of about 1 mM
arginine. Poly-L-arginine, however, may reduce arginine
bioavailability more profoundly at conditions with
reduced extracellular amounts of arginine and/or an
enhanced requirement for intracellular arginine. Such
conditions may occur in patients with asthma, due to
enhanced arginase and iNOS activities by airway epithe-
lial cells. Therefore, polycationic proteins in the airways of
asthmatics may give rise to exaggerated IL-6 and IL-8
responses by both the arginine uptake independent and
dependent mechanisms.
Conclusion
In conclusion, reduced bioavailability of arginine in the
airways may enhance inflammation by enhancing pro-
inflammatory mediator production by epithelial cells. As
pro-inflammatory peroxynitrites can also be produced at
low arginine availability, low local arginine concentra-
tions may be an important denominator in controlling
airway inflammation. Polycationic proteins/peptides also
enhance the epithelial pro-inflammatory mediator pro-
duction but this is not primarily regulated through
reduced arginine concentrations.
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